Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tali H Bar-Lev"'
Autor:
Michael Peled, Tali H Bar-Lev, Efrosiniia Talalai, Haggar Zoë Aspitz, Inbal Daniel-Meshulam, Jair Bar, Iris Kamer, Efrat Ofek, Adam Mor, Amir Onn
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0250178 (2021)
The most successful immunotherapeutic agents are blocking antibodies to either programmed cell death-1 (PD-1), an inhibitory receptor expressed on T lymphocytes, or to its ligand, programmed cell death-ligand 1 (PD-L1). Nevertheless, many patients do
Externí odkaz:
https://doaj.org/article/7d27f1932e944daabb8853575245260d
Autor:
Haggar Zoë Aspitz, Iris Kamer, Amir Onn, Inbal Daniel-Meshulam, Jair Bar, Tali H Bar-Lev, Efrat Ofek, Michael Peled, Efrosiniia Talalai, Adam Mor
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0250178 (2021)
PLoS ONE
PLoS ONE
The most successful immunotherapeutic agents are blocking antibodies to either programmed cell death-1 (PD-1), an inhibitory receptor expressed on T lymphocytes, or to its ligand, programmed cell death-ligand 1 (PD-L1). Nevertheless, many patients do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::863ca2df69ab5c56c20d83618e0d8b59
https://doi.org/10.1371/journal.pone.0250178
https://doi.org/10.1371/journal.pone.0250178